PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,496,000 | -52.9% | 658,092 | -83.5% | 6.50% | -69.7% |
| Q2 2020 | $13,794,000 | -17.9% | 3,998,094 | -27.2% | 21.46% | -20.0% |
| Q1 2020 | $16,802,000 | -11.7% | 5,490,994 | +48.8% | 26.82% | +1887.8% |
| Q3 2019 | $19,038,000 | -10.2% | 3,689,527 | +5.3% | 1.35% | +22.0% |
| Q2 2019 | $21,195,000 | +13.6% | 3,503,293 | +35.8% | 1.11% | -8.1% |
| Q1 2019 | $18,653,000 | – | 2,580,021 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |